Date: 2011-09-13
Name(s): Schuk, Carolyn
Description: Telecom operators today must find ways to differentiate their brand in a market where services and service providers are often indistinguishable. This report identifies the features that can be leveraged to provide product differentiation.
Date: 2011-10-20
Name(s): Marchant, Jeanette
Description: As increased emphasis is placed on cost effectiveness, getting the right drug to the right patient is crucial. Alliances between pharma and diagnostic companies are enabling the development of diagnostics that ensure that this can be a reality.
Date: 2011-12-21
Name(s): Marchant, Jeanette
Description: Between 2011 and 2015, patents on some 37 drugs with cumulative sales of $55bn are due to expire, of which 12 are mAbs, offering a growing number of opportunities for biosimilars, with market projections ranging between $2bn and $3bn by 2015.
Date: 2010-08-03
Name(s): Chi, Candace
Description: Big pharma has seen extensive layoffs to achieve cost-cutting necessitated by patent expiries, with manufacturing and sales being particularly affected, and outsourcing levels in R&D and manufacturing are expected to increase further in the future.
Date: 2011-08-08
Name(s): Gauba, Mike
Description: The convergence of digital video content, broadband and mobility has created an anytime, anywhere, any video paradigm, also popularly referred to as Mobile TV. Mobile TV is simply a capability that empowers the user to watch any video anywhere.
Date: 2010-08-03
Name(s): Gruenwald, Joerg
Description: Although the European directive on nutrition and health claims no. 1924/2006/EC, the European Parliament has established an EU-wide regulatory the evaluation procedure has created a great uncertainty among companies from the food and drink industry.
Date: 2011-08-31
Name(s): McCarthy, Nora
Description: Pharma is using social media increasingly to communicate with stakeholders. Social networks can be either open or closed and it is important that companies understand the difference between them and how they can best be used.
Date: 2011-03-16
Name(s): Malhotra, Girish
Description: The pharmaceutical industry faces ongoing challenges as blockbuster products continue to lose patent protection and generic companies gain market share. One way to maintain profitability is by improving API manufacturing processes.
Date: 2010-07-07
Name(s): Hill, Joanna
Description: In developed and highly competitive markets, packaging goes beyond merely containing and protecting the product to become a tool that adds value, are memorable, meaningful, differentiated, authentic, consistent, sustainable and flexible.
Date: 2008-09-18
Name(s): Sahoo, Alison
Description: In recent years, alliances between pharma and biotech companies have become common, with hundreds of relationships currently in place for drug developments across virtually all high priority conditions.
Date: 2011-04-12
Name(s): Norman, Peter
Description: Repositioning of drugs provides a low-cost, low-risk approach to the problems currently faced by the pharmaceutical industry including the end of the blockbuster model and the impending patent cliff.
Date: 2011-10-12
Description: The strategic utilization of drug delivery technologies is a critical development pathway for pharmaceutical companies to sustain revenues and market share for their patented products and extend their profitable lifecycle.
Date: 2011-09-30
Name(s): Qadir, Tanya
Description: As consumers expect companies to take a lead role in addressing sustainability concerns, it is crucial to understand how sustainability is reshaping the competitive landscape and build strategies to maximize the business benefits of sustainability.
Date: 2009-01-20
Name(s): Gruenwald, Joerg
Description: Driven by reports of adverse effects of synthetic ingredients, such as higher incidence of allergies or behavioral changes in kids, consumers are switching to natural ingredients - while awareness about the benefits of natural ingredients is growing.
Date: 2013
Name(s): Waldern, Barbara
